Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here.

A man wearing a hardhat looks up at a module being assembled at the international nuclear fusion project ITER in Saint-Paul-les-Durance, southern France.

A module being assembled at the international nuclear fusion project ITER in Saint-Paul-lez-Durance in southern France.Credit: Nicolas Tucat/AFP via Getty

The world’s biggest fusion-energy experiment, ITER, likely won’t be the first facility of its kind to hit a major milestone: creating more energy from a fusion reaction than is directly put into it. ITER’s major experiments have been pushed back by four years, to 2039, at a cost of more than US$5 billion. But physicists say that the project remains essential to building the foundations of a future fusion industry. “ITER is still going to be extremely relevant and extremely important, no matter when it comes,” says plasma physicist Rachael McDermott.

Nature | 7 min read

KataGo, a Go-playing AI system that can beat the world’s best human players, can be defeated by adversarial bots. These bots aren’t themselves good at the game — even amateurs can beat them — but they excel at feeding KataGo with inputs that cause it to make mistakes. Strategies for fortifying KataGo against such adversarial attacks mostly failed. “If we can’t solve the issue in a simple domain like Go, then in the near-term there seems little prospect of patching similar issues like jailbreaks in ChatGPT,” says AI researcher and study co-author Adam Gleave.

Nature | 5 min read

Reference: arXiv preprint (not peer reviewed)

The tectonic activity that forms our favourite planetary pointy bits might have begun something like 700 million years earlier than other evidence suggests. Geophysicists looked at ‘S-type’ zircons from Western Australia — the only material that survives from the Hadean Era, more than 4 billion years ago. They contain inclusions that could be evidence of continents and subduction — and thus the existence of plate tectonics — at the time they were formed, say researchers.

Science | 5 min read

Reference: Proceedings of the National Academy of Sciences paper

Features & opinion

Universities and institutions across the globe are finding ways of helping students and staff cope with the stress of academic life. Courses on mindfulness and mental health can help scientists — who often see their career as a calling — separate failures at work from their self-worth. Career workshops can target job insecurity, a key stressor for many academics. Critics argue that mental-health efforts won’t help scientists to win a grant or receive tenure. Others feel that the focus on individuals is needed to drive systemic changes. “My sense is that if I can empower the individual, then that individual can also push back,” says clinical psychologist Desiree Dickerson.

Nature | 9 min read

A new book by historian Joshua Blu Buhs is damning about the cultural role of Forteans — the granddaddy of anti-science movements. They pursue a mysticism-infused scepticism towards science that was inspired by Charles Fort (1874–1932), who dedicated his career to gathering accounts of unexplained anomalies. “They eroded the distinctions between truth and falsity, undermined the authority of experts and expertise,” writes Blu Buhs. “They launched a thousand conspiracies into the national consciousness.”

Nature | 6 min read

Researchers have taken great strides towards using faecal microbiota transplants (FMTs) to improve people’s response to immunotherapy. “We have now patients that are still alive, cancer free, four years after the first trial,” says oncologist Bertrand Routy. However, the composition of microbes in the gut differs from donor to donor, meaning that faecal transplants cannot be standardized and are hard to commercialize. “FMT is a stepping stone,” says cancer researcher Jennifer Wargo. The next phase will be to create uniform packages of known bacteria, or to replicate the effects of bacteria using drugs.

Nature | 12 min read

This article is part of Nature Outlook: The human microbiome, an editorially independent supplement produced with financial support from Yakult.

Where I work: Africa

Erna Blancquaert, wearing a headlamp and holding a bunch of grapes, standing beside MSc student Sindiswa Zandile in a vineyard.

Viticulture researcher Erna Blancquaert (right, with MSc student Sindiswa Zandile) starts work at dawn in the vineyards of South Africa’s celebrated Stellenbosch wine region. This time of day, before plant metabolism starts and the heat of the day sets in, is best for measuring the water status of grapevines and sampling fruit when its flavour is at its peak. Blancquaert and her team study the impact of sustainable and regenerative viticulture practices, such as using seaweed as a fertilizer and allowing cattle to graze in vineyards. (Nature Africa | 3 min readaussi en français)

See more of the Where I Work series from Nature Africa.

QUOTE OF THE DAY

Anthropologist Christopher Basaldú, a member of the Carrizo/Comecrudo Tribe of Texas, says that entrepreneur Elon Musk’s SpaceX rocket launches at Boca Chica are threatening fragile wildlife habitats and cutting off access for the people who have long relied on the land. (The New York Times | 16 min read)

This newsletter is always evolving — tell us what you think! Please send your feedback to briefing@nature.com.

Thanks for reading,

Flora Graham, senior editor, Nature Briefing

With contributions by Katrina Krämer, Smriti Mallapaty, Felicity Nelson and Sarah Tomlin

Want more? Sign up to our other free Nature Briefing newsletters:

Nature Briefing: Microbiology — the most abundant living entities on our planet — microorganisms — and the role they play in health, the environment and food systems.

Nature Briefing: Anthropocene — climate change, biodiversity, sustainability and geoengineering

Nature Briefing: AI & Robotics — 100% written by humans, of course

Nature Briefing: Cancer — a weekly newsletter written with cancer researchers in mind

Nature Briefing: Translational Research — covers biotechnology, drug discovery and pharma



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *